What TEA Navigator can do for Biotech Startups

Every technical decision has an economic consequence. TEA Navigator helps you understand both—before the investment is made.

TEA Navigator supports early-stage commercialization decisions, where startup teams are evaluating scale-up options, process yields, equipment configurations, and financing requirements before a detailed business case exists.

It links technical choices—such as fermentation scale, media preparation, sterilization, recovery yield, purification, drying, labor, and cold-chain logistics—directly to economic outcomes including COGS, capital investment, cash flow, profitability, NPV, IRR, and payback. This is especially valuable when R&D teams, engineers, founders, and investors need a shared quantitative view of commercialization risk.

Questions answered

• Can the startup become profitable at pilot scale?
• Which categories dominate COGS and operating profit?
• Which unit operation contributes most to manufacturing cost?
• Which bioreactor size provides the best economic return?
• At what production volume does commercialization become attractive?
• What production volume is required for the 5,000 L bioreactor to reach a 30% operating margin?
• What scale-up path gives the strongest balance of capital investment and operating cost?
• What HTST media-sterilization conditions achieve sterility while protecting media quality?

Commercialization analysis

Build the startup process

Create the block flow diagram for media preparation, HTST sterilization, production fermentation, purification, final drying, packaging, and finished product.

Review the baseline P&L

TEA Navigator calculates revenue, COGS, operating expenses, depreciation, operating profit, and operating margin to show whether the pilot-scale business is commercially viable.

Identify the largest cost contributors

Drill down by unit operation to compare media, fermentation, purification, drying, labor, utilities, validation, facilities, and cold-chain expenses.

Compare bioreactor scale-up alternatives

Compare 500 L, 2,000 L, 5,000 L, and 10,000 L fermenters using installed investment, labor, energy, maintenance, footprint, capacity, and fully loaded operating cost.

Update the selected scale-up scenario

Replace the pilot fermenter with a commercial option and immediately review the updated throughput, cost structure, gross margin, operating profit, and operating margin.

Determine the commercialization volume

Evaluate operating margin over a range of annual production volumes and identify the production scale required to support a commercially attractive startup business.

Computer modeling — the “T” in TEA

The same startup project connects commercialization economics to a physics-based HTST model for media sterilization and nutrient-quality retention.

HTST media sterilization

Predict product temperature, microbial lethality, cold-spot performance, and heat-related media-quality retention during continuous sterilization.

Evaluate how holding temperature, residence time, tube geometry, flow conditions, and heat transfer affect both sterility assurance and nutrient degradation.

What this startup example demonstrates

• One project connects the process design, startup P&L, unit-operation costs, equipment comparison, throughput analysis, and process modeling.
• Pilot-scale economics can be compared with commercial manufacturing options before major capital is committed.
• Bioreactor size, yield, labor, validation burden, and production volume strongly influence commercialization viability.
• Alternative scale-up scenarios can be evaluated using both technical capacity and financial return.
• The resulting analysis helps founders, R&D teams, engineers, and investors communicate using one quantitative model.